Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
29,149,043
-
Total 13F shares
-
13,117,480
-
Share change
-
-283,326
-
Total reported value
-
$348,994,653
-
Put/Call ratio
-
40%
-
Price per share
-
$26.61
-
Number of holders
-
133
-
Value change
-
+$1,167,845
-
Number of buys
-
76
-
Number of sells
-
53
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q3 2016
As of 30 Sep 2016,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,117,480 shares.
The largest 10 holders included
BlackRock Fund Advisors, Krensavage Asset Management, LLC, GREAT POINT PARTNERS LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, SENZAR ASSET MANAGEMENT, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, FMR LLC, AJO, LP, and BlackRock Institutional Trust Company, N.A..
This page lists
133
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.